Sustained activation and tumor targeting of NKT cells using a CD1d–anti-HER2–scFv fusion protein induce antitumor effects in mice

Kathrin Stirnemann(University of Lausanne), Alena Donda(University of Lausanne), H. Robson MacDonald(Hospital for Sick Children), Lucia Baldi(École Polytechnique Fédérale de Lausanne), Bruno Robert(Inserm), Valérie Cesson(Ludwig Cancer Research), Maurice Zauderer(Vaccinex (United States)), Florian Μ. Wurm(École Polytechnique Fédérale de Lausanne), Jean‐Pierre Mach(University of Lausanne), Jackeline F. Romero(University of Lausanne), Giampietro Corradin, Gurdyal S. Besra(University of Birmingham)
Journal of Clinical Investigation
February 1, 2008
Cited by 67


Related Papers